Follow
Willem Falkenburg
Willem Falkenburg
Verified email at sanquin.nl
Title
Cited by
Cited by
Year
Allogeneic HLA-A* 02–restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuity
WJJ Falkenburg, JJ Melenhorst, M van de Meent, MGD Kester, ...
The Journal of Immunology 187 (5), 2824-2833, 2011
402011
IgG subclass specificity discriminates restricted IgM rheumatoid factor responses from more mature anti–citrullinated protein antibody–associated or isotype‐switched IgA responses
WJJ Falkenburg, D van Schaardenburg, P Ooijevaar‐de Heer, G Wolbink, ...
Arthritis & rheumatology 67 (12), 3124-3134, 2015
322015
Anti-hinge antibodies recognize IgG subclass–and protease-restricted neoepitopes
WJJ Falkenburg, D Van Schaardenburg, P Ooijevaar-de Heer, ...
The Journal of Immunology 198 (1), 82-93, 2017
232017
Clinically relevant discrepancies between different rheumatoid factor assays
WJJ Falkenburg, HJ Von Richthofen, J Koers, C Weykamp, MWJ Schreurs, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 56 (10), 1749-1758, 2018
212018
Stimulation of Naďve Monocytes and PBMC s with Coagulation Proteases Results in Thrombin‐Mediated and PAR‐1‐Dependent Cytokine Release and Cell Proliferation in PBMC s Only
L Nieuwenhuizen, WJJ Falkenburg, REG Schutgens, G Roosendaal, ...
Scandinavian Journal of Immunology 77 (5), 339-349, 2013
202013
Evolution of autoantibody responses in individuals at risk of rheumatoid arthritis
WJJ Falkenburg, D van Schaardenburg
Best Practice & Research Clinical Rheumatology 31 (1), 42-52, 2017
162017
Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation
WJJ Falkenburg, AC Kempers, G Dekkers, P Ooijevaar-de Heer, ...
Rheumatology 56 (11), 2025-2030, 2017
122017
On the origin of rheumatoid factors: Insights from analyses of variable region sequences
WJJ Falkenburg, HJ von Richthofen, T Rispens
Seminars in arthritis and rheumatism 48 (4), 603-610, 2019
102019
Identification of clinically and pathophysiologically relevant rheumatoid factor epitopes by engineered IgG Targets
WJJ Falkenburg, N Oskam, J Koers, L van Boheemen, ...
Arthritis & Rheumatology 72 (12), 2005-2016, 2020
62020
Tsang-A-Sjoe MWP, Bultink IEM, Voskuyl AE, et al
WJJ Falkenburg, D van Schaardenburg, P Ooijevaar-de Heer
Anti-hinge antibodies recognize IgG subclass–and protease-restricted …, 2017
52017
Allogeneic HLA-A2-Restricted WT1-Specific T Cells From Mismatched Donors Are Highly Reactive but Show Potentially Hazardous Promiscuity.
WJJ Falkenburg, JJ Melenhorst, MGD Kester, P Hombrink, ...
Blood 114 (22), 4081, 2009
22009
Elevated Fab glycosylation of anti-hinge antibodies
J Koers, NIL Derksen, WJJ Falkenburg, P Ooijevaar-de Heer, ...
Scandinavian Journal of Rheumatology, 1-8, 2021
12021
Rheumatoid factors may potentiate immune complex formation of anti-citrullinated protein antibodies
WJJ Falkenburg, D van Schaardenburg, J Koers, P Ooijevaar-de Heer, ...
ARTHRITIS & RHEUMATOLOGY 68, 2016
12016
FRI0019 Anti-IGG Subclass Specific Rheumatoid Factor Discriminates Between Restricted and Polyspecific RF Responses which are Associated with Isotype Switching and ACPA Positivity
W Falkenburg, D Van Schaardenburg, P Ooijevaar-de Heer, G Wolbink, ...
Annals of the Rheumatic Diseases 74 (Suppl 2), 425-425, 2015
12015
Rheumatoid factors
WJJ Falkenburg
2020
SAT0017 The rheumatoid factor response is composed of multiple reactivities against different epitopes
W Falkenburg, J Koers, P Oijevaar-de Heer, D van Schaardenburg, ...
Annals of the Rheumatic Diseases 77 (Suppl 2), 876-877, 2018
2018
AB0082 Clinically relevant discrepancies between different rheumatoid factor assays
W Falkenburg, H von Richthofen, J Koers, C Weykamp, M Schreurs, ...
Annals of the Rheumatic Diseases 77 (Suppl 2), 1238-1238, 2018
2018
FRI0038 Anti-Hinge Antibodies Recognize IGG Subclass-and Protease-Restricted Hinge neo-Epitopes
W Falkenburg, D van Schaardenburg, P Ooijevaar-de Heer, ...
Annals of the Rheumatic Diseases 75 (Suppl 2), 439-440, 2016
2016
THU0510 Igg ACPA Level Increase Drives Rheumatoid Factor Response Maturation in Patients before Onset of Clinically Apparent Rheumatoid Arthritis
W Falkenburg, WH Bos, A Sohrabian, J Rönnelid, G Wolbink, ...
Annals of the Rheumatic Diseases 73 (Suppl 2), 359-360, 2014
2014
Properties of allogeneic WT1126–134-specific CD8+ T cells generated across an HLA A2 barrier
JJ Melenhorst, WJJ Falkenburg, E Gostick, MF Quigley, NF Hensel, ...
Cancer Research 70 (8_Supplement), 4776-4776, 2010
2010
The system can't perform the operation now. Try again later.
Articles 1–20